| 2022-11-07 |
详情>>
股本变动：
变动后总股本47566.76万股
变动原因 ▼▲
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-09-01 |
详情>>
业绩披露：
2021年中报每股收益0.75元,归母净利润333.29亿元,同比去年增长221.00%
|
| 2021-04-22 |
详情>>
业绩披露：
2020年年报每股收益0.56元,归母净利润249.56亿元,同比去年增长-59.12%
|
| 2020-10-20 |
股东大会：
将于2020-11-20召开股东大会
会议内容 ▼▲
- 1.“THAT the Supplemental Agreement in relation to certain amendments to the Existing Non- Compete Undertaking be and is hereby approved, ratified and confirmed and that any director of the Company be and is hereby authorised to do all such further acts and things and execute such further documents or supplemental agreements or deeds on behalf of the Company and take all such steps which in his or her opinion may be necessary, desirable or expedient to implement and/or give effect to the terms of the Supplemental Agreement.”
|
| 2020-09-01 |
详情>>
业绩披露：
2020年中报每股收益0.23元,归母净利润103.83亿元,同比去年增长-65.68%
|
| 2020-04-22 |
详情>>
业绩披露：
2019年年报每股收益1.37元,归母净利润610.45亿元,同比去年增长15.86%
|
| 2020-04-08 |
股东大会：
将于2020-05-21召开股东大会
会议内容 ▼▲
- As ordinary business, to consider and, if thought fit, pass with or without amendments, the following ordinary resolutions:
1.To receive and consider the audited financial statements together with the Report of the Directors and Independent Auditors’ Report thereon for the year ended 31 December 2019.
2.To declare a final dividend for the year ended 31 December 2019.
3.To re-elect Mr. Hu Guangjie (“Mr. Hu”) as an Executive Director of the Company.
4.To re-elect Mr. Lawrence J. Lau (“Mr. Lau”), who has already served the Company for more than nine years, as an Independent Non-executive Director of the Company.
5.To re-elect Mr. Tse Hau Yin, Aloysius (“Mr. Tse”), who has already served the Company for more than nine years, as an Independent Non-executive Director of the Company.
6.To authorise the Board to fix the remuneration of each of the Directors.
7.To re-appoint Deloitte Touche Tohmatsu as the independent auditors of the Company and its subsidiaries, and to authorise the Board to fix the remuneration of the independent auditors.
As special business, to consider and, if thought fit, pass with or without amendments, the following resolutions as ordinary resolutions:
8.“THAT:
(a)subject to paragraph (b) below, the exercise by the Directors during the Relevant Period (as hereinafter defined) of all the powers of the Company to buy back shares in the capital of the Company on the Stock Exchange or on any other exchange on which the shares of the Company may be listed and recognised by the Securities and Futures Commission of Hong Kong and the Stock Exchange for this purpose (“Recognised Stock Exchange”), subject to and in accordance with all applicable laws, rules and regulations and the requirements of the Listing Rules, or of any other Recognised Stock Exchange and the Articles, be and is hereby generally and unconditionally approved;
(b)the aggregate number of shares of the Company which the Company is authorised to buy back pursuant to the approval in paragraph (a) above shall not exceed 10% of the total number of issued shares of the Company as at the date of the passing of this resolution;
(c)for the purposes of this resolution:
“Relevant Period” means the period from the date of the passing of this resolution until whichever is the earlier of:
(i)the conclusion of the next annual general meeting of the Company following the passing of this resolution;
(ii)the date on which the authority given under this resolution is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.”
9.“THAT:
(a)subject to the following provisions of this resolution, the exercise by the Directors during the Relevant Period (as hereinafter defined) of all the powers of the Company to issue, allot and deal with additional shares in the capital of the Company and to make or grant offers, agreements, options and similar rights to subscribe for or convert any security into shares in the Company (including bonds, notes, warrants, debentures and securities convertible into shares of the Company) which would or might require the exercise of such powers be and is hereby generally and unconditionally approved;
(b)the approval in paragraph (a) above shall authorise the Directors during the Relevant Period to make or grant offers, agreements, options and similar rights to subscribe for or convert any security into shares in the Company (including bonds, notes, warrants, debentures and securities convertible into shares of the Company) which would or might require the exercise of such powers after the end of the Relevant Period;
(c)the aggregate number of shares of the Company allotted or agreed conditionally or unconditionally to be allotted (whether pursuant to an option or otherwise) and any options, warrants or rights to be issued or granted by the Directors pursuant to the approval in paragraph (a) above, otherwise than pursuant to:
(i)a Rights Issue (as hereinafter defined);
(ii)an issue of shares pursuant to any specific authority granted by shareholders of the Company in general meeting, including upon the exercise of rights of subscription or conversion under the terms of any warrants issued by the Company or any bonds, notes, debentures or securities convertible into shares of the Company;
(iii)the grant of options and the exercise of any option granted under any share option scheme or similar arrangement for the time being adopted by the Company and/or any of its subsidiaries;
(iv)any scrip dividend or similar arrangement providing for the allotment of shares in lieu of the whole or part of a dividend on shares of the Company in accordance with the Articles;
(v)any adjustment, after the date of grant or issue of any options, rights to subscribe for or convert any security into shares or other securities referred to above, in the price at which shares in the Company shall be subscribed, and/or in the number of shares in the Company which shall be subscribed, on exercise of relevant rights under such options, warrants or other securities, such adjustment being made in accordance with, or as contemplated by, the terms of such options, rights to subscribe or other securities, shall not exceed 20% of the total number of issued shares of the Company as at the date of the passing of this resolution; and that this resolution shall be limited by the applicable rules and requirements of the Stock Exchange as amended from time to time, including the restrictions for using the approval in paragraph (a) above to issue (i) securities convertible into new shares for cash consideration, if the initial conversion price of such convertible securities is lower than the Benchmarked Price (as hereinafter defined) of the Shares at the time of the relevant placing; and (ii) warrants, options or similar rights to subscribe for new shares or securities convertible into new shares for cash consideration.
(d)for the purposes of this resolution:
“Relevant Period” means the period from the date of passing of this resolution until whichever is the earlier of:
(i)the conclusion of the next annual general meeting of the Company following the passing of this resolution;
(ii)the date on which the authority given under this resolution is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.
10.“THAT subject to the passing of the resolutions numbered B1 and B2 as set out in the notice convening this meeting, the general mandate granted to the Board to issue, allot and deal with additional shares of the Company and to make or grant offers, agreements, options and similar rights to subscribe for or convert any security into shares in the Company pursuant to resolution numbered B2 as set out in this notice be and is hereby extended by the addition to it of an amount representing the aggregate number of shares of the Company which are bought back by the Company pursuant to and since the granting to the Company of the general mandate to buy back shares in accordance with resolution numbered B1 as set out in this notice, provided that such extended amount shall not exceed 10% of the total number of issued shares of the Company as at the date of the passing of this resolution.”
|
| 2020-03-25 |
除权日：
美东时间 2020-06-03 每股派息5.20美元
|
| 2019-11-06 |
股东大会：
将于2019-11-21召开股东大会
会议内容 ▼▲
- ORDINARY RESOLUTIONS
1.“THAT the Non-exempt Continuing Connected Transactions as described in the circular of the Company dated 6 November 2019, which the Company expects to occur on a regular and continuous basis in the ordinary and usual course of business of the Company and its subsidiaries, as the case may be, and to be conducted on normal commercial terms, be and are hereby generally and unconditionally approved and confirmed and that any Director of the Company be and is hereby authorised to do all such further acts and things and execute such further documents and take all such steps which in their opinion may be necessary, desirable or expedient to implement and/or give effect to the terms of such transactions.”
2.“THAT the relevant Proposed Caps for each category of the Non-exempt Continuing Connected Transactions as set out in the circular of the Company dated 6 November 2019, be and are hereby approved, ratified and confirmed.”
|
| 2019-09-09 |
详情>>
业绩披露：
2019年中报每股收益0.68元,归母净利润302.53亿元,同比去年增长18.75%
|
| 2019-05-07 |
股东大会：
将于2019-05-23召开股东大会
会议内容 ▼▲
- A.As ordinary business, to consider and, if thought fit, pass with or without amendments, the following ordinary resolutions:
1.To receive and consider the audited financial statements together with the Report of the Directors and Independent Auditors’ Report thereon for the year ended 31 December 2018.
2.To declare a final dividend for the year ended 31 December 2018.
3.To re-elect Mr. Wang Dongjin as a Non-executive Director of the Company: Wang Dongjin
4.To re-elect Mr. Xu Keqiang as an Executive Director of the Company: Xu Keqiang
5.To re-elect Mr. Chiu Sung Hong, who has already served the Company for more than nine years, as an Independent Non-executive Director of the Company: Chiu Sung Hong
6.To re-elect Mr. Qiu Zhi Zhong as an Independent Non-executive Director of the Company
7.To authorise the Board to fix the remuneration of each of the Directors.
8.To re-appoint Deloitte Touche Tohmatsu as the independent auditors of the Company and its subsidiaries, and to authorise the Board to fix the remuneration of the independent auditors.
B.As special business, to consider and, if thought fit, pass with or without amendments, the following resolutions as ordinary resolutions:
1.“THAT:
(a)subject to paragraph (b) below, the exercise by the Directors during the Relevant Period (as hereinafter defined) of all the powers of the Company to buy back shares in the capital of the Company on the Stock Exchange or on any other exchange on which the shares of the Company may be listed and recognized by the Securities and Futures Commission of Hong Kong and the Stock Exchange for this purpose (“Recognized Stock Exchange”), subject to and in accordance with all applicable laws, rules and regulations and the requirements of the Listing Rules, or of any other Recognized Stock Exchange and the Articles of the Association of the Company, be and is hereby generally and unconditionally approved;
(b)the aggregate number of shares of the Company which the Company is authorised to buy back pursuant to the approval in paragraph (a) above shall not exceed 10% of the total number of issued shares of the Company as at the date of the passing of this resolution;
(c)for the purposes of this resolution:
“Relevant Period” means the period from the date of the passing of this resolution until whichever is the earlier of:
(i)the conclusion of the next annual general meeting of the Company following the passing of this resolution;
(Ii)the date on which the authority given under this resolution is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.
2.“THAT:
(a)subject to the following provisions of this resolution, the exercise by the Directors during the Relevant Period (as hereinafter defined) of all the powers of the Company to issue, allot and deal with additional shares in the capital of the Company and to make or grant offers, agreements, options and similar rights to subscribe for or convert any security into shares in the Company (including bonds, notes, warrants, debentures and securities convertible into shares of the Company) which would or might require the exercise of such powers be and is hereby generally and unconditionally approved;
(b)the approval in paragraph (a) above shall authorise the Directors during the Relevant Period to make or grant offers, agreements, options and similar rights to subscribe for or convert any security into shares in the Company (including bonds, notes, warrants, debentures and securities convertible into shares of the Company) which would or might require the exercise of such powers after the end of the Relevant Period;
(c)the aggregate number of shares of the Company allotted or agreed conditionally or unconditionally to be allotted (whether pursuant to an option or otherwise) and any options, warrants or rights to be issued or granted by the Directors pursuant to the approval in paragraph (a) above, otherwise than pursuant to:
(i)a Rights Issue ( as hereinafter defined);
(iI)an issue of shares pursuant to any specific authority granted by shareholders of the Company in general meeting, including upon the exercise of rights of subscription or conversion under the terms of any warrants issued by the Company or any bonds, notes, debentures or securities convertible into shares of the Company;
(iii)the grant of options and the exercise of any option granted under any share option scheme or similar arrangement for the time being adopted by the Company and/or any of its subsidiaries;
(iv)any scrip dividend or s imilar arrangement providing for the al lotment of shares in l ieu of the whole or part of a dividend on shares of the Company in accordance with the Articles of the Association of the Company;
(v)any adjustment, after the date of grant or issue of any options, rights to subscribe for or convert any security into shares or other securities referred to above, in the price at which shares in the Company shall be subscribed, and/or in the number of shares in the Company which shall be subscribed, on exercise of relevant rights under such options, warrants or other securities, such adjustment being made in accordance with, or as contemplated by, the terms of such options, rights to subscribe or other securities, shall not exceed 20% of the total number of issued shares of the Company as at the date of the passing of this resolution; and that this resolution shall be limited by the applicable rules and requirements of the Stock Exchange as amended from time to time, including the restrictions for using the Share Issue Mandate to issue (i) securities convertible into new Shares for cash consideration, if the initial conversion price of such convertible securities is lower than the Benchmarked Price (as hereinafter defined) of the Shares at the time of the relevant placing; and (ii) warrants, options or similar rights to subscribe for new Shares or securities convertible into new Shares for cash consideration.
(d)for the purposes of this resolution:
“Relevant Period” means the period from the date of passing of this resolution until whichever is the earlier of:
(i)the conclusion of the next annual general meeting of the Company following the passing of this resolution;
(ii)the date on which the authority given under this resolution is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.
“Benchmarked Price” means the higher of (a) the closing price on the date of the relevant placing agreement or other agreement involving the proposed issue of securities under the general mandate to be approved under this resolution; and (b) the average closing price in the 5 trading days immediately prior to the earlier of: (i) the date of announcement of the placing or the proposed transaction or arrangement involving the proposed issue of securities under the general mandate to be approved under this resolution; (ii) the date of the placing agreement or other agreement involving the proposed issue of securities under the general mandate to be approved under this resolution; and (iii) the date on which the placing or subscription price is fixed.
“Rights Issue” means an offer of shares open for a period fixed by the Directors made to holders of shares whose names appear on the register of members of the Company on a fixed record date in proportion to their then holdings of such shares (subject to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to fractional entitlements or having regard to any restrictions or obligations under the laws of, or the requirements of, any recognized regulatory body or any stock exchange in or in any territory outside Hong Kong).”
3.“THAT subject to the passing of the resolutions numbered B1 and B2 as set out in the notice convening this meeting, the general mandate granted to the Board to issue, allot and deal with additional shares of the Company and to make or grant offers, agreements, options and similar rights to subscribe for or convert any security into shares in the Company pursuant to resolution numbered B2 set out in this notice be and is hereby extended by the addition to it of an amount representing the aggregate number of shares of the Company which are bought back by the Company pursuant to and since the granting to the Company of the general mandate to buy back shares in accordance with resolution numbered B1 set out in this notice, provided that such extended amount shall not exceed 10% of the total number of issued shares of the Company as at the date of the passing of this resolution.”
|
| 2019-04-23 |
详情>>
业绩披露：
2018年年报每股收益1.18元,归母净利润526.88亿元,同比去年增长113.51%
|
| 2018-09-04 |
详情>>
业绩披露：
2018年中报每股收益0.57元,归母净利润254.77亿元,同比去年增长56.78%
|
| 2018-04-19 |
详情>>
业绩披露：
2017年年报每股收益0.55元,归母净利润246.77亿元,同比去年增长3773.94%
|
| 2018-04-12 |
股东大会：
将于2018-05-31召开股东大会
会议内容 ▼▲
- A.As ordinary business, to consider and, if thought fit, pass with or without amendments, the following ordinary resolutions:
1.To receive and consider the audited financial statements together with the Report of the Directors and Independent Auditors’ Report thereon for the year ended 31 December 2017.
2.To declare a final dividend for the year ended 31 December 2017.
3.To re-elect Mr. Yang Hua as a Non-executive Director of the Company
4.To re-elect Mr. Wu Guangqi as a Non-executive Director of the Company
5.To re-elect Mr. Tse Hau Yin, Aloysius, who has already served the Company for more than nine years, as an Independent Non-executive Director of the Company
6.To authorise the Board to fix the remuneration of each of the Directors
7.To re-appoint Deloitte Touche Tohmatsu as the independent auditors of the Company and its subsidiaries, and to authorise the Board to fix the remuneration of the independent auditors.
B.As special business, to consider and, if thought fit, pass with or without amendments, the following resolutions as ordinary resolutions:
1.“THAT:
1.1subject to paragraph (b) below, the exercise by the Directors during the Relevant Period (as hereinafter defined) of all the powers of the Company to buy back shares in the capital of the Company on the Stock Exchange or on any other exchange on which the shares of the Company may be listed and recognized by the Securities and Futures Commission of Hong Kong and the Stock Exchange for this purpose (“Recognized Stock Exchange”), subject to and in accordance with all applicable laws, rules and regulations and the requirements of the Listing Rules, or of any other Recognized Stock Exchange and the Articles of the Company, be and is hereby generally and unconditionally approved;
1.2the aggregate number of shares of the Company which the Company is authorised to buy back pursuant to the approval in paragraph (a) above shall not exceed 10% of the total number of issued shares of the Company as at the date of the passing of this resolution;
1.3for the purposes of this resolution:
“Relevant Period” means the period from the date of the passing of this resolution until whichever is the earlier of:
1.3.1 the conclusion of the next annual general meeting of the Company following the passing of this resolution;
1.3.2the date on which the authority given under this resolution is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.”
2.“THAT:
2.1subject to the following provisions of this resolution, the exercise by the Directors during the Relevant Period (as hereinafter defined) of all the powers of the Company to issue, allot and deal with additional shares in the capital of the Company and to make or grant offers, agreements, options and similar rights to subscribe for or convert any security into shares in the Company (including bonds, notes, warrants, debentures and securities convertible into shares of the Company) which would or might require the exercise of such powers be and is hereby generally and unconditionally approved;
2.2the approval in paragraph (a) above shall authorise the Directors during the Relevant Period to make or grant offers, agreements, options and similar rights to subscribe for or convert any security into shares in the Company (including bonds, notes, warrants, debentures and securities convertible into shares of the Company) which would or might require the exercise of such powers after the end of the Relevant Period;
2.3the aggregate number of shares of the Company allotted or agreed conditionally or unconditionally to be allotted (whether pursuant to an option or otherwise) and any options, warrants or rights to be issued or granted by the Directors pursuant to the approval in paragraph (a) above, otherwise than pursuant to:
2.3.1a Rights Issue (as hereinafter defined);
2.3.2an issue of shares pursuant to any specific authority granted by shareholders of the Company in general meeting, including upon the exercise of rights of subscription or conversion under the terms of any warrants issued by the Company or any bonds, notes, debentures or securities convertible into shares of the Company;
2.3.3the grant of options and the exercise of any option granted under any share option scheme or similar arrangement for the time being adopted by the Company and/or any of its subsidiaries;
2.3.4any scrip dividend or similar arrangement providing for the allotment of shares in lieu of the whole or part of a dividend on shares of the Company in accordance with the Articles of the Company;
2.3.5any adjustment, after the date of grant or issue of any options, rights to subscribe for or convert any security into shares or other securities referred to above, in the price at which shares in the Company shall be subscribed, and/or in the number of shares in the Company which shall be subscribed, on exercise of relevant rights under such options, warrants or other securities, such adjustment being made in accordance with, or as contemplated by, the terms of such options, rights to subscribe or other securities,shall not exceed 20% of the total number of issued shares of the Company as at the date of the passing of this resolution;
2.4for the purposes of this resolution:
“Relevant Period” means the period from the date of passing of this resolution until whichever is the earlier of:
2.4.1the conclusion of the next annual general meeting of the Company following the passing of this resolution;
2.4.2the date on which the authority given under this resolution is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.
“Rights Issue” means an offer of shares open for a period fixed by the Directors made to holders of shares whose names appear on the register of members of the Company on a fixed record date in proportion to their then holdings of such shares (subject to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to fractional entitlements or having regard to any restrictions or obligations under the laws of, or the requirements of, any recognized regulatory body or any stock exchange in or in any territory outside Hong Kong).”
3.“THAT subject to the passing of the resolutions numbered B1 and B2 as set out in the notice convening this meeting, the general mandate granted to the Board to issue, allot and deal with additional shares of the Company and to make or grant offers, agreements, options and similar rights to subscribe for or convert any security into shares in the Company pursuant to resolution numbered B2 set out in this notice be and is hereby extended by the addition to it of an amount representing the aggregate number of shares of the Company which are bought back by the Company pursuant to and since the granting to the Company of the general mandate to buy back shares in accordance with resolution numbered B1 set out in this notice, provided that such extended amount shall not exceed 10% of the total number of issued shares of the Company as at the date of the passing of this resolution.”
|
| 2017-09-05 |
详情>>
业绩披露：
2017年中报每股收益0.36元,归母净利润162.50亿元,同比去年增长310.08%
|
| 2017-08-24 |
除权日：
美东时间 2017-09-14 每股派息2.56美元
|
| 2017-04-21 |
详情>>
业绩披露：
2016年年报每股收益0.01元,归母净利润6.37亿元,同比去年增长-96.85%
|
| 2017-03-23 |
除权日：
美东时间 2017-06-06 每股派息2.96美元
|
| 2016-11-16 |
股东大会：
将于2016-12-01召开股东大会
会议内容 ▼▲
- 1. “THAT the Non-exempt Continuing Connected Transactions as described in the Circular, which the Company expects to occur on a regular and continuous basis in the ordinary and usual course of business of the Company and its subsidiaries, as the case may be, and to be conducted on normal commercial terms, be and are hereby generally and unconditionally approved and confirmed and that any Director of the Company be and is hereby authorised to do all such further acts and things and execute such further documents and take all such steps which in their opinion may be necessary, desirable or expedient to implement and/or give effect to the terms of such transactions.”
2. “THAT the relevant Proposed Caps for each category of the Non-exempt Continuing Connected Transactions, as described in the Circular, be and are hereby approved, ratified and confirmed.”
|
| 2016-08-24 |
除权日：
美东时间 2016-09-06 每股派息1.55美元
|
| 2016-04-06 |
股东大会：
将于2016-05-26召开股东大会
会议内容 ▼▲
- A.As ordinary business, to consider and, if thought fit, pass with or without amendments, the following ordinary resolutions:
1.To receive and consider the audited financial statements together with the Report of the Directors and Independent Auditors’ Report thereon for the year ended 31 December 2015.
2.To declare a final dividend for the year ended 31 December 2015.
3.To re-elect Mr. Li Fanrong as an Executive Director of the Company: Li Fanrong
4.To re-elect Mr. Lv Bo as a Non-executive Director of the Company: Lv Bo
5.To re-elect Mr. Chiu Sung Hong, who has already served the Company for more than nine years, as an Independent Non-executive Director of the Company: Chiu Sung Hong
B.As special business, to consider and, if thought fit, pass with or without amendments, the following resolutions as ordinary resolutions:
1.“THAT:
(a)subject to paragraph (b) below, the exercise by the Directors during the Relevant Period (as hereinafter defined) of all the powers of the Company to buy back shares in the capital of the Company on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) or on any other exchange on which the shares of the Company may be listed and recognized by the Securities and Futures Commission of Hong Kong and the Stock Exchange for this purpose (“Recognized Stock Exchange”), subject to and in accordance with all applicable laws, rules and regulations and the requirements of the Listing Rules, or of any other Recognized Stock Exchange and the Articles of the Company, be and is hereby generally and unconditionally approved;
(b)the aggregate number of shares of the Company which the Company is authorised to buy back pursuant to the approval in paragraph (a) above shall not exceed 10% of the total number of issued shares of the Company as at the date of the passing of this resolution;
(c)for the purposes of this resolution:
“Relevant Period” means the period from the date of the passing of this resolution until whichever is the earlier of:
(i)the conclusion of the next annual general meeting of the Company following the passing of this resolution;
(ii)the date on which the authority given under this resolution is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.”
2.“THAT:
(a)subject to the following provisions of this resolution, the exercise by the Directors during the Relevant Period (as hereinafter defined) of all the powers of the Company to issue, allot and deal with additional shares in the capital of the Company and to make or grant offers, agreements, options and similar rights to subscribe for or convert any security into shares in the Company (including bonds, notes, warrants, debentures and securities convertible into shares of the Company) which would or might require the exercise of such powers be and is hereby generally and unconditionally approved;
(b)the approval in paragraph (a) above shall authorise the Directors during the Relevant Period to make or grant offers, agreements, options and similar rights to subscribe for or convert any security into shares in the Company (including bonds, notes, warrants, debentures and securities convertible into shares of the Company) which would or might require the exercise of such powers after the end of the Relevant Period;
(c)the aggregate number of shares of the Company allotted or agreed conditionally or unconditionally to be allotted (whether pursuant to an option or otherwise) and any options, warrants or rights to be issued or granted by the Directors pursuant to the approval in paragraph (a) above, otherwise than pursuant to:
(i)a Rights Issue (as hereinafter defined);
(ii)an issue of shares pursuant to any specific authority granted by shareholders of the Company in general meeting, including upon the exercise of rights of subscription or conversion under the terms of any warrants issued by the Company or any bonds, notes, debentures or securities convertible into shares of the Company;
(iii)the grant of options and the exercise of any option granted under any share option scheme or similar arrangement for the time being adopted by the Company and/or any of its subsidiaries;
(iv)any scrip dividend or similar arrangement providing for the allotment of shares in lieu of the whole or part of a dividend on shares of the Company in accordance with the Articles of the Company;
(v)any adjustment, after the date of grant or issue of any options, rights to subscribe for or convert any security into shares or other securities referred to above, in the price at which shares in the Company shall be subscribed, and/or in the number of shares in the Company which shall be subscribed, on exercise of relevant rights under such options, warrants or other securities, such adjustment being made in accordance with, or as contemplated by, the terms of such options, rights to subscribe or other securities, shall not exceed 20% of the total number of issued shares of the Company as at the date of the passing of this resolution;
(d)for the purposes of this resolution:
“Relevant Period” means the period from the date of passing of this resolution until whichever is the earlier of:
(i)the conclusion of the next annual general meeting of the Company following the passing of this resolution;
(ii)the date on which the authority given under this resolution is revoked or varied by an ordinary resolution of the shareholders of the Company in general meeting.
“Rights Issue” means an offer of shares open for a period fixed by the Directors made to holders of shares whose names appear on the register of members of the Company on a fixed record date in proportion to their then holdings of such shares (subject to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to fractional entitlements or having regard to any restrictions or obligations under the laws of, or the requirements of, any recognized regulatory body or any stock exchange in or in any territory outside Hong Kong).”
3.“THAT subject to the passing of the resolutions numbered B1 and B2 as set out in the notice convening this meeting, the general mandate granted to the Board to issue, allot and deal with additional shares of the Company and to make or grant offers, agreements, options and similar rights to subscribe for or convert any security into shares in the Company pursuant to resolution numbered B2 set out in this notice be and is hereby extended by the addition to it of an amount representing the aggregate number of shares of the Company which are bought back by the Company pursuant to and since the granting to the Company of the general mandate to buy back shares in accordance with resolution numbered B1 set out in this notice, provided that such extended amount shall not exceed 10% of the total number of issued shares of the Company as at the date of the passing of this resolution.”
|
| 2016-03-24 |
除权日：
美东时间 2016-06-06 每股派息3.22美元
|
| 2015-08-27 |
除权日：
美东时间 2015-09-08 每股派息3.23美元
|
| 2015-04-10 |
股东大会：
将于2015-05-21召开股东大会
会议内容 ▼▲
- 1.To receive and consider the audited financial statements together with the Report of the Directors and Independent Auditors’ Report thereon for the year ended 31 December 2014.
2.To declare a final dividend for the year ended 31 December 2014.
3.To re-elect Mr. Wu Guangqi as an Executive Director of the Company.
4.To re-elect Mr. Yang Hua as a Non-executive Director of the Company.
5.To re-elect Mr. Tse Hau Yin, Aloysius, who has already served the Company for more than nine years, as an Independent Non-executive Director of the Company.
6.To authorise the Board to fix the remuneration of each of the Directors.
7.To re-appoint Deloitte Touche Tohmatsu as the independent auditors of the Company and its subsidiaries, and to authorize the Board to fix the remuneration of the independent auditors.
|
| 2015-03-27 |
除权日：
美东时间 2015-06-02 每股派息4.13美元
|
| 2014-04-09 |
股东大会：
将于2014-05-23召开股东大会
会议内容 ▼▲
- 1. To receive and consider the audited Statement of Accounts together with the Report of the Directors and Independent Auditors’ Report thereon for the year ended 31 December 2013.
2. To declare a final dividend for the year ended 31 December 2013.
3. To re-elect Mr. Li Fanrong as an Executive Director of the Company;
4. To re-elect Mr. Wang Yilin as a Non-executive Director of the Company;
5. To re-elect Mr. Lv Bo as a Non-executive Director of the Company;
6. To re-elect Mr. Zhang Jianwei as a Non-executive Director of the Company;
7. To re-elect Mr. Wang Jiaxiang as a Non-executive Director of the Company;
8. To re-elect Mr. Lawrence J. Lau as an Independent Non-executive Director of the Company;
9. To re-elect Mr . Kevin G . Lynch as an Independent Non-executive Director of the Company;
10. To authorise the Board to fix the remuneration of each of the Directors.
11. To re-appoint Deloitte Touche Tohmatsu as the independent auditors of the Company and its subsidiaries, and to authorize the Board to fix the remuneration of the independent auditors.
|
| 2014-04-01 |
除权日：
美东时间 2014-06-03 每股派息4.13美元
|
| 2013-08-23 |
除权日：
美东时间 2013-09-03 每股派息3.22美元
|
| 2013-03-25 |
除权日：
美东时间 2013-05-28 每股派息4.13美元
|
| 2012-08-21 |
除权日：
美东时间 2012-09-04 每股派息1.93美元
|
| 2012-04-05 |
除权日：
美东时间 2012-05-25 每股派息3.61美元
|
| 2011-08-25 |
除权日：
美东时间 2011-09-01 每股派息3.21美元
|
| 2011-03-23 |
除权日：
美东时间 2011-05-16 每股派息3.21美元
|
| 2010-08-23 |
除权日：
美东时间 2010-08-30 每股派息2.70美元
|